The Chronically Mentally Ill

  • Shirley M. Glynn
Part of the Critical Issues in Psychiatry book series (CIPS)

Abstract

In working with the chronically mentally ill, empirical investigations and clinical treatments share many similarities. Both require a commitment to interacting with relatively impaired patients whose gains can typically be measured best after months or years of intervention, rather than days or weeks. Both involve working with patients who frequently have limited resources, lead impoverished lives, and require as much aid in the “nuts and bolts” of living as they do symptom relief. Finally, at least at our present level of knowledge, both researchers and clinicians who are working with the chronically mentally ill must be prepared to be confronted with the limits of their efforts. Whether they work in academic research settings or in public mental health clinics, psychiatrists and other mental health professionals must anticipate that, regardless of the intervention, the majority of chronically mentally ill patients are unable to return to their highest level of premorbid functioning (Stephens, 1978) and that some minority of patients appear to achieve very limited benefits from either psychopharmacologic and/or psychosocial treatments (Davis, Schaffer, Killian, Kinard, & Chan, 1980).

Keywords

Schizophrenic Patient Cognitive Therapy Social Adjustment Veteran Administration Residential Facility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.Google Scholar
  2. Bachrach, L. (1988). Defining chronic mental illness: A concept paper. Hospital and Community Psychiatry, 39, 383–388.PubMedGoogle Scholar
  3. Beck, A., Rush, A., Shaw, B., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.Google Scholar
  4. Boudewyns, P. A., & Shipley, R. H. (1983). Flooding and implosive therapy: Direct therapeutic exposure in clinical practice. New York: Plenum Press.CrossRefGoogle Scholar
  5. Brown, V., Ridgely S., Pepper, B., Levine, I., & Ryglewicz, H. (1989). The dual crisis: Mental illness and substance abuse. American Psychologist, 44, 565–569.PubMedCrossRefGoogle Scholar
  6. Carpenter, W., Kirkpatrick, B., & Buchanan, R. (1990). Conceptual approaches to the study of schizophrenia. In A. Kales, C. Stefanis, & J. Talbott (Eds.), Recent advances in schizophrenia (pp. 95–113). New York: Springer-Verlag.CrossRefGoogle Scholar
  7. Casey, P., Tyrer, P., & Platt, S. (1985). The relationship between social functioning and psychiatric symptomatology in primary care. Social Psychiatry, 20, 5–9.PubMedCrossRefGoogle Scholar
  8. Ciompi, L. (1980a). Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin, 6, 606–618.PubMedCrossRefGoogle Scholar
  9. Ciompi, L. (1980b). Three lectures on schizophrenia. British Journal of Psychiatry, 136, 413–420.PubMedCrossRefGoogle Scholar
  10. Crow, T. (1980). Molecular pathology of schizophrenia: More than one dimension of pathology? British Medical Journal, 280, 66–68.PubMedCrossRefGoogle Scholar
  11. Crow, T. (1985). The two-syndrome concept: Origins and current status. Schizophrenia Bulletin, 11, 471–486.PubMedCrossRefGoogle Scholar
  12. Davis, J., Schaffer, C., Killian, G., Kinard, C., & Chan, C. (1980). Important issues in the drug treatment of schizophrenia. Schizophrenia Bulletin, 5, 109–126.Google Scholar
  13. Derogatis, L. (1977). The SCL-90 Manual: Administration, and procedure for the SCL-90. Baltimore: Johns Hopkins University, School of Medicine.Google Scholar
  14. Elkin, I., Shea, T., Watkins, J., Imber, S., Sotsky, S., Collins, J., Glass, D., Pilkonis, P., Leber, W., Docherty, J., Fiester, S., & Parioff, M. (1989). National Institute of Mental Health treatment of depression collaborative research program. Archives of General Psychiatry, 46, 971–983.PubMedCrossRefGoogle Scholar
  15. Falloon, I. (1984). Relapse: A reappraisal of assessment of outcome in schizophrenia. Schizophrenia Bulletin, 10, 293–299.PubMedCrossRefGoogle Scholar
  16. Falloon, I., Boyd, J., McGill, C., Razani, J., Moss, H., & Gilderman, A. (1982). Family management in the prevention of exacerbations of schizophrenia. New England Journal of Medicine, 306, 1437–1440.PubMedCrossRefGoogle Scholar
  17. Geller, E., Ritvo, E., & Freeman, B. (1982). Preliminary observations on the effects of fenfluramine on blood serotonin and symptoms in three autistic boys. New England Journal of Medicine, 307, 165–169.PubMedCrossRefGoogle Scholar
  18. Goldstrom, I., & Manderscheid, R. (1982). The chronically mentally ill: A descriptive analysis from the uniform client data instrument. Community Support Services Journal, 2, 4–9.Google Scholar
  19. Haas, G., Glick, I., Clarkin, J., Spencer, J., & Lewis, A. (1990). Gender and schizophrenia outcome: A clinical trial of an inpatient family intervention. Schizophrenia Bulletin, 16, 277–292.PubMedCrossRefGoogle Scholar
  20. Harding, C., Brooks, G., Ashikaga, T., Strauss, J., & Breier, A. (1987a). The Vermont longitudinal study of persons with severe mental illness: I. Methodology, study sample, and overall status 32 years later. American Journal of Psychiatry, 144, 718–726.PubMedGoogle Scholar
  21. Harding, C., Brooks, G., Ashikaga, T., Strauss, J., & Breier, A. (1987b). The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry, 144, 727–735.PubMedGoogle Scholar
  22. Heinrichs, D., Hanlon, T., & Carpenter, W. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 3, 388–398.CrossRefGoogle Scholar
  23. Hogarty, G., Anderson, C., Reiss, D., Kornblith, S., Greenwald, D., Javna, C., & Madonia, M. (1986). Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. Archives of General Psychiatry, 43, 633–642.PubMedCrossRefGoogle Scholar
  24. Katz, M., & Lyerly, S. (1963). Methods for measuring adjustment and social behavior in the community: I. Rationale, description, discriminative validity and scale development. Psychological Reports, 13, 503–535.CrossRefGoogle Scholar
  25. Keane, T., Fairbank, J., Caddell, J., & Zimering, R. (1989). Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behavior Therapy, 20, 245–260.CrossRefGoogle Scholar
  26. Klerman, G., Weissman, W., Rounsaville, B., & Chevron, E. (1984). Interpersonal psychotherapy of depression. New York: Basic Books.Google Scholar
  27. Kraepelin, E. (1915). Lehrbuch der Psychiatrie [Clinical psychiatry]. (Translated from the 7th German edition by A. R. Diefendorf.) New York: Scholars’ Facsimiles and Reprints.Google Scholar
  28. Lin, K., Poland, R., Nuccio, I., Matsuda, K., Hathuc, N., Su, T., & Fu, P. (1989). A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. American Journal of Psychiatry, 146, 1307–1311.PubMedGoogle Scholar
  29. Marshall, B., Glynn, S., Midha, K., Hubbard, J., Bowen, L., Banzett, L., Mintz, J., & Liberman, R. (1989). Adverse effects of fenfluramine in treatment refractory schizophrenia. Journal of Clinical Psychopharmacology, 9, 110–115.PubMedCrossRefGoogle Scholar
  30. McGlashan, T. (1986). Predictors of shorter-, medium-, and longer-term outcome in schizophrenia. American Journal of Psychiatry, 143, 50–55.PubMedGoogle Scholar
  31. Mogul, K. (1985). Psychological considerations in the use of psychotropic drugs with women patients. Hospital and Community Psychiatry, 36, 1080–1085.PubMedGoogle Scholar
  32. Overall, J., & Gorham, D. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812.CrossRefGoogle Scholar
  33. Platt, S., Weyman, A., Hirsch, S., & Hewett, S. (1980). The Social Behaviour Assessment Schedule (SBAS): Rationale, contents, scoring and reliability of a new interview schedule. Social Psychiatry, 15, 43–55.CrossRefGoogle Scholar
  34. Ritvo, E., Freeman, B., & Yuwiler, A. (1986). Fenfluramine treatment of autism: UCLA collaborative study of 810 patients at nine medical centers. Psychopharmacology Bulletin, 22, 133–140.PubMedGoogle Scholar
  35. Schatzberg, A., & Cole, J. (Eds.). (1986). Manual of clinical psychopharmacology. Washington, DC: American Psychiatric Press.Google Scholar
  36. Schinnar, A., Rothbard, A., Kanter, R., & Adams, K. (1990). Crossing state lines of mental illness. Hospital and Community Psychiatry, 41, 756–760.PubMedGoogle Scholar
  37. Schooler, N., & Keith, S. (1983). National Institute of Mental Health cooperative agreement program protocol for treatment strategies in schizophrenia study. Unpublished manuscript.Google Scholar
  38. Schwartz, C., Myers, J., & Astrachan, B. (1975). Concordance of multiple assessments of the outcome of schizophrenia. Archives of Psychiatry, 32, 1221–1227.CrossRefGoogle Scholar
  39. Seeman, M. (1986). Current outcome in schizophrenia: Women versus men. Acta Psychiatrica Scandinavica, 73, 609–617.PubMedCrossRefGoogle Scholar
  40. Shea, M., Pilkonis, P., Beckham, E., Collins, J., Elkin, I., Sotsky, S., & Docherty, J. (1990). Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. American Journal of Psychiatry, 147, 711–718.PubMedGoogle Scholar
  41. Shore, D., Korpi, E., & Bigelow, L. (1985). Fenfluramine and chronic schizophrenia. Biological Psychiatry, 20, 329–352.CrossRefGoogle Scholar
  42. Simons, A., Murphy, G., Levine, J., & Wetzel, R. (1986). Cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 43, 43–48.PubMedCrossRefGoogle Scholar
  43. Spitzer, R., & Williams, J. (1985). Structured Clinical Interview for DSM-III-R, Patient version. New York: New York State Psychiatric Institute, Biometrics Research Department.Google Scholar
  44. Stephens, J. (1978). Long-term prognosis and follow-up in schizophrenia. Schizophrenia Bulletin, 4, 25–47.PubMedCrossRefGoogle Scholar
  45. Strauss, J., & Carpenter, W. (1972). The prediction of outcome in schizophrenia. Archives of General Psychiatry, 27, 739–746.PubMedCrossRefGoogle Scholar
  46. Tolsodorf, C. (1976). Social networks, support and coping. Family Process, 15, 407–418.CrossRefGoogle Scholar
  47. Wahl, O. (1977). Sex bias in schizophrenia research: A short report. Journal of Abnormal Psychology, 86, 195–198.PubMedCrossRefGoogle Scholar
  48. Weissman, M. (1975). The assessment of social adjustment. Archives of General Psychiatry, 32, 357–365.PubMedCrossRefGoogle Scholar
  49. Weissman, M., & Paykel, E. (1974). Social adjustment scale. In Weissman, M., & Paykel, E. (Eds.), The depressed woman (pp. 236–264). Chicago: University of Chicago Press.Google Scholar
  50. Wing, J., Cooper, J., & Sartorius, N. (1974). The measurement and classification of psychiatric symptoms. London: Cambridge University Press.Google Scholar
  51. Woods, P., Higson, P., & Tannahill, M. (1984). Token-economy programmes with chronic psychotic patients: The importance of direct measurement and objective evaluation for long-term maintenance. Behaviour Research and Therapy, 22, 41–51.PubMedCrossRefGoogle Scholar
  52. World Health Organization. (1980). ICD-9-CM: International classification of diseases, 9th revision, clinical modification. Ann Arbor: Commission on Professional and Hospital Activities.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Shirley M. Glynn
    • 1
  1. 1.Veterans Administration Medical Center of West Los AngelesLos AngelesUSA

Personalised recommendations